Patient organisations
At NovalGen, fostering open dialogue and transparent communication with patient organisations is integral to our commitment to patients and caregivers.
Recognising the invaluable insights and perspectives they offer, patient organisations serve as vital partners in our decision-making processes across the entire lifecycle of our medicines. We are dedicated to actively engaging with these organisations, ensuring that their voices are heard and their needs are addressed as we continue our mission to find innovative solutions that change the lives of patients worldwide.
More in this section
Clinical trials
NovalGen is committed to developing innovative treatments.
Treatments
NovalGen is focused on bispecific antibody treatment.